GlassScriptPhysician profile
Emilio Del Priore
NPI 1326082496
$2,524.52
in general payments reported to CMS, 2019-2025
13 companies · $708 in 2025
The $708 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $508 · 2021: $603 · 2022: $184 · 2023: $295 · 2024: $227 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,229.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $938.74 | 2021-2025 | Rybelsus, Ozempic |
| Abbott Laboratories | $478.06 | 2020-2023 | Jot Dx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $393.63 | 2020-2021 | |
| Lilly USA, LLC | $165.80 | 2023-2025 | Mounjaro, Zepbound |
| Abiomed | $149.96 | 2025 | |
| Esperion Therapeutics, INC. | $147.49 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.25 | 2025 | |
| Amgen INC. | $41.16 | 2025 | Repatha |
| Novartis Pharmaceuticals Corporation | $30.54 | 2025 | |
| Janssen Pharmaceuticals, INC | $29.03 | 2024 | Xarelto |
| Medicomp INC | $26.91 | 2025 | Telepatch Cardiac Monitor |
| Intra-Sana Laboratories | $24.06 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.89 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emilio Del Priore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.